Advertisement
Screener

EDITAS MEDICINE, INC. (EDIT) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

EDITAS MEDICINE, INC. Cash Flow Breakdown

Cash flow breakdown shows where EDITAS MEDICINE, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $165.24M went out.
  • Fiscal year ended 2025-12-31: from investing, $138.67M came in.
  • Fiscal year ended 2025-12-31: from financing, $40.47M came in.
  • Fiscal year ended 2025-12-31: change in cash, $13.90M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew debtNew shares soldNot split outChange in cash
2025-12-31-$165.24M$138.67M-$2.87M$42.85M$13.90M
2024-12-31-$210.28M$162.15M$0.00$57.00M$0.00-$973.00K*$7.89M
2023-12-31-$132.18M-$3.73M$117.08M$960.00K*-$17.87M
2022-12-31-$177.35M$114.07M$0.00$1.28M*-$62.00M
2021-12-31-$163.80M-$54.47M$249.46M$32.65M*$63.84M
2020-12-31-$179.84M-$140.52M$203.73M$20.40M*-$96.24M
2019-12-31-$40.67M$12.25M$116.34M$15.48M*$103.41M
2018-12-31-$45.71M-$53.09M$76.79M$10.15M*-$11.85M
2017-12-31-$9.42M-$183.81M$154.14M-$38.69M
2016-12-31-$50.25M-$3.47M$97.49M$43.44M
2015-12-31-$5.44M-$1.43M-$2.08M*$141.47M*$132.56M
2014-12-31-$8.65M-$1.22M$18.48M*$8.61M

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew shares soldNot split outChange in cash
2026-06-30-$29.57M*-$29.80M*$0.00*$117.50M*
2026-03-31-$23.06M$64.00K$0.00$0.00-$23.00M
2025-12-31-$36.39M*$58.00K*$0.00*$17.08M*
2025-09-30-$30.84M*$39.57M*$0.00*$17.15M*
2025-06-30-$50.21M*$42.65M*$0.00*$7.18M*
2025-03-31-$47.80M$56.39M-$2.87M$1.44M$7.15M
2024-12-31-$50.76M*$30.96M*$0.00*$0.00*$55.51M*
2024-09-30-$52.59M*$83.98M*$0.00*$0.00*
2024-06-30-$57.06M*$51.95M*$0.00*$0.00*
2024-03-31-$49.87M-$4.75M$0.00$0.00-$54.42M
2023-12-31-$22.24M*$62.84M*$0.00*$514.00K*
2023-09-30-$35.46M*-$102.82M*$0.00*
2023-06-30-$38.71M*$12.98M*$11.00K*$117.51M*
2023-03-31-$35.77M$23.27M$0.00-$12.50M
2022-12-31-$42.27M*-$27.53M*$0.00*$619.00K*
2022-09-30-$48.00M*$89.23M*$80.00K*
2022-06-30-$37.84M*-$4.00M*$0.00*
2022-03-31-$49.23M$56.37M$218.00K$7.36M
2021-12-31-$34.58M*-$22.84M*$1.00K*$1.06M*
2021-09-30-$40.78M*-$39.66M*$0.00*$2.50M*
2021-06-30-$38.96M*$4.79M*-$11.00K*$17.09M*
2021-03-31-$49.48M$3.24M$249.47M$12.00M*$215.24M
2020-12-31-$40.10M*-$108.89M*-$113.00K*$9.21M*
2020-09-30-$54.80M*-$152.26M*-$125.00K*$947.00K*
2020-06-30-$30.86M*$74.17M*$6.84M*$204.31M*
2020-03-31-$54.09M$46.46M$3.05M-$4.58M
2019-12-31$41.02M*$7.82M*$75.13M*$9.44M*
2019-09-30-$26.88M*-$122.30M*$2.14M*$41.22M*
2019-06-30-$25.81M*$76.11M*$2.09M*
2019-03-31-$29.00M$50.63M$1.53M$23.16M
2018-12-31$1.33M*-$8.60M*$28.32M*$2.03M*
2018-09-30-$7.84M*-$13.62M*$0.00*$1.24M*
2018-06-30-$16.73M*-$71.68M*-$3.00K*$2.67M*
2018-03-31-$22.46M$40.82M$48.47M$4.21M*$71.04M
2017-12-31-$25.07M*$26.68M*$57.46M*$1.02M*
2017-09-30-$27.98M*-$28.85M*$0.00*-$730.00K*-$57.55M*
2017-06-30-$26.16M*-$180.99M*-$417.00K*-$207.46M*
2017-03-31$69.79M-$656.00K$97.10M$166.23M
2016-12-31-$13.68M*$963.00K*$0.00*-$538.00K*-$14.55M*
2016-09-30-$17.04M*-$713.00K*-$196.00K*-$17.78M*
2016-06-30-$9.90M*-$1.16M*-$498.00K*-$11.55M*
2016-03-31-$9.63M-$2.56M$98.18M$86.02M
2015-12-31-$7.97M*-$401.00K*-$1.93M*-$1.82M*-$12.12M*
2015-09-30-$11.94M*-$190.00K*-$42.00K*$120.43M*$108.26M*
2015-06-30$20.45M*-$535.00K*$21.96M*$41.87M*
2015-03-31-$5.94M-$305.00K$791.00K*-$5.46M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Eikon Therapeutics, Inc. (EIKN)United States$0.446B
Zura Bio Ltd (ZURA)$0.398B-6.56
Surrozen, Inc./DE (SRZN)United States$0.395B
AGENUS INC (AGEN)United States$0.383B1.41
Tectonic Therapeutic, Inc. (TECX)United States$0.469B-7.68
C4 Therapeutics, Inc. (CCCC)United States$0.373B-5.65
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
REGENXBIO Inc. (RGNX)United States$0.477B-3.30